AYSEGUL A SAHIN to Mice, SCID
This is a "connection" page, showing publications AYSEGUL A SAHIN has written about Mice, SCID.
Connection Strength
0.075
-
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells. J Immunother Cancer. 2021 03; 9(3).
Score: 0.035
-
Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies. FASEB J. 2014 Jan; 28(1):364-72.
Score: 0.021
-
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. J Clin Invest. 2012 Jun; 122(6):2066-78.
Score: 0.019